Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Barrick Offers to Buy Rest of Project to Resolve Government Dispute

The situation and the gold major's proposal are discussed in a Haywood report. In a May 23 research note, Haywood analyst Kerry Smith reported that Barrick Gold Corp. (ABX:TSX; GOLD:NYSE) proposed to acquire the remaining 36.1% interest in Acacia, taking Barrick ...

Transportation Index Points To Stock Markets Weakness

The recent news that the US and China will restart trade talks resulted in a fairly large upside price rotation as this “good news” suggests that some resolution to the trade issues may be in the works soon. Yet we want to warn traders that the US will li...

Silver Could Be Close To An Important Resolution

Silver is still in consolidation mode since early September, but could be close to a resolution. Below, is chart of silver: On the chart there appears to have formed some fractals. The current one has also broken out at the blue line in middle to late December of ...

Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug

Sarepta Therapeutics shares traded 35% higher after the firm reported that the FDA approved its second RNA exon-skipping treatment drug VYONDYS 53 injection for the treatment of Duchenne's Muscular Dystrophy in patients amenable to skipping Exon 53. Yesterday evening,...

Buzz on the Bullboards: More tricks than treats in today’s stock market?

It has been an uneasy week for markets on Bay Street and Wall Street. After the TSX hit a two-week low a few days ago, the Bank of Canada voted to keep interest rates at 5 per cent, kicking off a risk rally. U.S. markets have also fared well as optimism grows that...

These 3 Charts Will Convince Investors That Time May Be Running Out

Before we get to looking at those three charts, let’s talk about the trade war. On Friday the Trump administration made good on its threat to raise tariffs on as much as $200 billion worth of Chinese imports to 25 percent from the previous 10 percent. The ...

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...

The Expected and Thrilling Resolution of Oil’s Consolidation

Let's take a closer look at the chart below (chart courtesy of www.stooq.com ) and assess the likely crude oil price path ahead. Yesterday, we wrote: (…) On Friday, crude oil futures bounced off the green gap, which brought about quite a sharp move to the upside....

Oil’s Ongoing Struggle at Multiple Resistances. Resolution Just Ahead?

Although crude oil futures moved a bit higher yesterday, the major resistance zone created by three gaps and the 61.8% Fibonacci retracement again stopped the buyers. A pullback followed, and the futures invalidated the earlier breakout above the previous peaks. Tog...

Buzz on the Bullboards: Tracking the Major Movers: Opportunities & Warnings

(Image via New Found Gold Corp.) Markets have been increasingly volatile in recent weeks. While these erratic swings can tend to fray the nerves of investors, the flip side of this is that gains can now be made in a matter of weeks (or even days) that would equate t...
1 2 3 4 5 6 7 8 9 10 ...